BC-2126

N/A

Report date: 2025/01/26 15:01:20
NME

Base Information

Drug NameBC-2126
Drug Alias NameBC-2126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsRespiratory Tract InfectionsPseudomonas Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNabriva Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesNabriva Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii InfectionsRespiratory Tract InfectionsPseudomonas Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A